$2.91
+0.14 (+4.93%)
Open$2.92
Previous Close$2.77
Day High$2.92
Day Low$2.91
52W High$141.50
52W Low$2.40
Volume—
Avg Volume31.6K
Market Cap3.53M
P/E Ratio—
EPS$-27.15
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.61M | 6.76M | 8.11M |
| Net Income | 881.2K | 841.9K | 1.08M |
| Profit Margin | 11.6% | 12.5% | 13.3% |
| EBITDA | 1.17M | 1.13M | 1.25M |
| Free Cash Flow | 539.3K | 438.1K | 671.3K |
| Rev Growth | -2.4% | +10.1% | +12.1% |
| Debt/Equity | 0.23 | 0.23 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |